Abstract WP223: Race-ethnic Differences in the Impact of Antithrombotic Use on Inpatient Mortality Among Intracerebral Hemorrhage Patients in the Florida Stroke Registry (2013–2024)
This analysis reveals varied inpatient mortality from antithrombotic use in intracerebral hemorrhage patients by race-ethnicity, suggesting implications for healthcare strategies.
Key Points
To examine the relationship between race-ethnicity and types of antithrombotic use on inpatient mortality in intracerebral hemorrhage patients.
Analyzed data from 32,036 ICH patients in the Florida Stroke Registry (2013–2024)
Categorized antithrombotic exposure into anticoagulant-associated, antiplatelet-only, and non-antithrombotic
Utilized multivariable logistic regression models to assess race-ethnicity interactions with adjusted variables
Inpatient mortality was 16% overall, with trends showing a decrease among all groups from 2013 to 2024
AA ICH had the highest adjusted mortality among NH Black patients (AOR=2.01)
AP ICH also showed significantly higher mortality compared to NA ICH for NH Black patients (AOR=1.37)